BC
Boxer Capital Portfolio holdings
AUM
$2.04B
This Quarter Return
+59.64%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$883M
AUM Growth
+$883M
(-5.6%)
Cap. Flow
-$83.4M
Cap. Flow
% of AUM
-9.44%
Top 10 Holdings %
Top 10 Hldgs %
73.41%
Holding
36
New
4
Increased
6
Reduced
5
Closed
10
Top Buys
| 1 |
Solid Biosciences
SLDB
|
$72.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
$49.6M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$26.6M |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
$20.3M |
| 5 |
Esperion Therapeutics
ESPR
|
$18.6M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$111M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$46.1M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$24.5M |
| 4 |
PTC Therapeutics
PTCT
|
$23.6M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$22.9M |
Sector Composition
| 1 | Healthcare | 94.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Syndax Pharmaceuticals
SNDX
$1.41B
| $702K | 0.08% |
100,000
| – | – |
|
|
BPMC
27
DELISTED
Blueprint Medicines
BPMC
| – | – |
-250,000
| Closed | -$22.9M |
|
28
Ionis Pharmaceuticals
IONS
$6.79B
| – | – |
-312,000
| Closed | -$13.8M |
|
29
Neurogene
NGNE
$264M
| – | – |
-747,500
| Closed | -$10.5M |
|
|
GTHX
30
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – |
-660,000
| Closed | -$24.5M |
|
|
BLCM
31
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| – | – |
-350,000
| Closed | -$2.3M |
|
|
ONTXW
32
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| – | – |
-241,644
| Closed | -$72K |
|
|
DERM
33
DELISTED
Dermira, Inc.
DERM
| – | – |
-500,000
| Closed | -$4M |
|
|
LOXO
34
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-400,000
| Closed | -$46.1M |
|
|
AVXS
35
DELISTED
AveXis, Inc. Common Stock
AVXS
| – | – |
-900,000
| Closed | -$111M |
|
|
LJPC
36
DELISTED
La Jolla Pharmaceutical Company
LJPC
| – | – |
-267,500
| Closed | -$7.97M |
|